SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056378
Filing Date
2021-11-12
Accepted
2021-11-12 06:03:28
Documents
44
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20210930.htm   iXBRL 10-Q 1373728
2 EX-31.1 mnov-ex311_7.htm EX-31.1 11009
3 EX-31.2 mnov-ex312_6.htm EX-31.2 11021
4 EX-32.1 mnov-ex321_9.htm EX-32.1 7904
5 EX-32.2 mnov-ex322_8.htm EX-32.2 7892
  Complete submission text file 0001564590-21-056378.txt   4008808

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnov-20210930.xsd EX-101.SCH 27364
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20210930_cal.xml EX-101.CAL 31384
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20210930_def.xml EX-101.DEF 74730
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20210930_lab.xml EX-101.LAB 255440
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20210930_pre.xml EX-101.PRE 180088
11 EXTRACTED XBRL INSTANCE DOCUMENT mnov-10q_20210930_htm.xml XML 488921
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 211398867
SIC: 2834 Pharmaceutical Preparations